| Value | ₹5.56 Cr |
|---|---|
| Execution period | Within Two (02) Months |
BSE filing, NSE: BGPL. Summary written from the filing by ALFA Finder's alert engine.
String Metaverse Ltd: key numbers
- Share price
- ₹6.97
- Market cap
- ₹991.9 Cr
- Revenue (annual)
- ₹1,069 Cr
- Net profit (annual)
- ₹102.5 Cr
- P/E (TTM)
- 8.2×Sector 22.9×
- Promoter holding
- 74.98%+0.03% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from String Metaverse Ltd
All →String Metaverse Management Change
String Metaverse Ltd appointed Dr. Sethurathnam Ravi as Director Emeritus in an honorary and advisory capacity, effective October 20, 2026.
String Metaverse Preferential Issue
String Metaverse Ltd announced EGM voting results, where shareholders approved the special resolution for the issue of equity shares on a preferential basis.
String Metaverse Other Announcement
String Metaverse Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
String Metaverse Preferential Issue
String Metaverse's EGM placed a preferential issue of up to 8.32 crore shares at ₹8.85 each for approval. The resolution covers approximately ₹73.63 crore in fresh equity capital.
- Value
- ₹73.63 Cr
String Metaverse Preferential Issue
String Metaverse Ltd received BSE in-principle approval for a preferential issue of 8.32 crore shares at Rs. 8.85 each. The issue is valued at Rs. 73.63 crore.
- Value
- ₹73.63 Cr
String Metaverse Management Change
Mr. Sethurathnam Ravi resigned as Chairman and Non-Executive Director of String Metaverse Ltd, effective September 30, 2026.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.